Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

MeSH terms

• Antiviral Agents / therapeutic use*
• Female
• Hepatitis C, Chronic / drug therapy*
• Hepatitis C, Chronic / epidemiology*
• Humans
• Male